Immunocore Holdings plc (IMCR) Misses Q4 EPS by 20c

Immunocore Holdings plc (NASDAQ: IMCR) reported Q4 EPS of ($0.40), $0.20 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $70.16 million versus the consensus estimate of $53.23 million.

For earnings history and earnings-related data on Immunocore Holdings plc (IMCR) click here.

You May Also Be Interested In

• NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
• Morgan Stanley Starts Amplifon SpA (AMP:IM) (AMFPF) at Overweight
• UBS Upgrades Zhejiang Leapmotor Technology (9863:HK) to Buy